Related Experiment Video
Updated: Jul 4, 2025

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
The Early Onset of Levodopa-induced Dyskinesia in a Patient with Multiple System Atrophy
Shohei Okusa1,2, Jin Nakahara1,2, Morinobu Seki1,2
1Department of Neurology, Keio University School of Medicine, Japan.
Abstract:
Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by Parkinsonism, cerebellar ataxia, and autonomic dysfunction. While less frequent than Parkinson's disease, MSA patients with a beneficial levodopa response may occasionally present with levodopa-induced dyskinesia (LID). We herein report a 50-year-old woman diagnosed with MSA-parkinsonism who developed LID in the unilateral lower extremity 10 months after the start of levodopa treatment. In this case, the distribution of LID, the timing of its onset, and the presence of LID despite relatively poor levodopa responsiveness were distinctive.
Insights
Multiple system atrophy (MSA) patients may develop levodopa-induced dyskinesia (LID). This case highlights unique LID presentation in an MSA patient, even with limited levodopa response.
Area of Science:
- Neurodegenerative diseases
- Movement disorders
- Pharmacology
Background:
- Multiple system atrophy (MSA) is a rare neurodegenerative disorder.
- MSA presents with parkinsonism, ataxia, and autonomic dysfunction.
- Levodopa-induced dyskinesia (LID) can occur in MSA patients, though less common than in Parkinson's disease.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Neural Regulation
Lysosomal Hydrolases

